Table 1 Response rate and characteristics of the 1507 European rheumatologists who were respondents to the questionnaire evaluating the ASAS/EULAR recommendations for the management of ankylosing spondylitis (AS)
CharacteristicsArabian Gulf (n = 89)Belgium (n = 84)Czech Republic (n = 73)France (n = 413)Germany (n = 301)Italy (n = 172)Netherlands (n = 73)Norway (n = 72)Spain (n = 119)UK (n = 111)All countries (n = 1507)
Respondents (%)28.528.820.916.027.049.130.236.010.917.320.9
Distribution across countries (% of all respondents)5.95.64.827.420.011.44.84.87.97.4100
Men (%)79.862.227.460.163.168.665.847.260.575.762.1
Age (years), mean (SD)46.4 (6.5)49.1 (10.8)47.8 (8.8)48.3 (8.9)50.9 (8.5)48.7 (10.2)51.1 (7.7)50.0 (9.5)46.8 (9.3)45.8 (8.4)48.6 (9.1)
Number of years of practice, mean (SD)14.1 (7.6)18.3 (10.7)15.8 (7.9)18.5 (8.7)15.6 (9.6)17.6 (9.9)16.0 (8.6)14.1 (9.2)18.0 (9.9)14.7 (8.3)16.8 (9.3)
Academic position (%)65.227.419.213.177.722.119.225.028.619.833.8
Number of rheumatic patients seen a month, mean (SD)188.9 (133.1)220.3 (126.4)268.6 (192.9)275.1 (159.9)224.7 (202.7)160.8 (120.5)277.7 (162.7)123.7 (222.2)302.1 (143.7)217.6 (153.7)234.4 (171.7)
    Range8–8003–50020–75020–12005–10005–80040–8500–180040–85010–12500–1800
Number of patients with AS seen per month, mean (SD)10.1 (32.7)15.4 (13.5)16.8 (16.7)12.0 (25.9)25.0 (43.3)9.9 (12.5)23.9 (61.1)12.7 (10.0)18.4 (16.6)12.9 (9.8)15.6 (29.8)
    Range1–3001–502–701–4151–6001–1001–5100–401–1002–600–600